Skip to main content
Top
Published in: Journal of Endocrinological Investigation 2/2017

01-02-2017 | Original Article

Breast cancer and thyroid diseases: analysis of 867 consecutive cases

Authors: C. Chiappa, F. Rovera, S. Rausei, S. Del Ferraro, A. Fachinetti, M. Lavazza, V. Marchionini, V. Arlant, M. L. Tanda, E. Piantanida, H. Y. Kim, A. Anuwong, G. Dionigi

Published in: Journal of Endocrinological Investigation | Issue 2/2017

Login to get access

Abstract

Introduction

The aim of this study was to evaluate the association of breast cancer with thyroid diseases. Many authors have already studied the possible relationship between these two diseases, but the results are nowadays conflicting.

Materials and methods

Our study examining 867 patients with breast cancer (862 women and 5 men, average age = 61 years old) of whom 141 also had thyroid disease evaluated the recurrence of thyroid diseases and their association with different types of breast cancer. Statistical analyses were performed using SPSS software for Windows; we used nonparametric tests (Chi-square and Mann–Whitney), and the level of significance was set at p < 0.05.

Results

We found a significant association between breast cancer diagnosed after menopause and thyroid disease (p < 0.003). Moreover, we analyzed the role of thyroid autoimmunity identifying an association between chronic autoimmune thyroiditis and breast cancer diagnosed before menopause (p < 0.05). Regarding receptor profile of breast carcinoma, we have found an increased expression of estrogen receptors in patients with autoimmune thyroiditis compared to patients with any other thyroid diseases (p < 0.03). Contrariwise, we do not have found any difference between the group with every thyroid disease and the group without thyroid disease (p < 1.00). We did not find other statistically significant associations with breast cancer’s parameters like family history, tumor size, lymph node metastasis, distant metastasis, cancer clinical and pathological stage, differentiation grade and expression of Ki67, p53 and Her2 in the two main groups with or without thyroid disease. Likewise, we did not found other statistically significant association between hypothyroidism or hyperthyroidism and breast cancer.
Literature
1.
go back to reference Dionigi G et al (2014) Intraoperative neuromonitoring in thyroid surgery: a point prevalence survey on utilization, management, and documentation in Italy. Updates Surg 66(4):269–276CrossRefPubMed Dionigi G et al (2014) Intraoperative neuromonitoring in thyroid surgery: a point prevalence survey on utilization, management, and documentation in Italy. Updates Surg 66(4):269–276CrossRefPubMed
2.
go back to reference Myhill J et al (1966) Thyroid function in breast cancer. Acta Endocrinol (Copenh) 51(2):290–300 Myhill J et al (1966) Thyroid function in breast cancer. Acta Endocrinol (Copenh) 51(2):290–300
4.
go back to reference Muller I et al (2011) High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest 34(5):349–352CrossRefPubMed Muller I et al (2011) High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest 34(5):349–352CrossRefPubMed
5.
go back to reference Michalaki V et al (2009) Breast cancer in association with thyroid disorders. J Balk Union Oncol 14(3):425–428 Michalaki V et al (2009) Breast cancer in association with thyroid disorders. J Balk Union Oncol 14(3):425–428
6.
go back to reference Grani G et al (2012) Thyroid diseases in women with breast cancer. Clin Ter 163(6):e401–e404PubMed Grani G et al (2012) Thyroid diseases in women with breast cancer. Clin Ter 163(6):e401–e404PubMed
7.
go back to reference Tazebay UH et al (2000) The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6(8):871–878CrossRefPubMed Tazebay UH et al (2000) The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6(8):871–878CrossRefPubMed
8.
go back to reference An JH et al (2015) A possible association between thyroid cancer and breast cancer. Thyroid 25(12):1330–1338CrossRefPubMed An JH et al (2015) A possible association between thyroid cancer and breast cancer. Thyroid 25(12):1330–1338CrossRefPubMed
9.
go back to reference Davies TF (1994) The thyrotrophin receptors spread themselves around. J Clin Endocrinol Metabol 79:1232–1238 Davies TF (1994) The thyrotrophin receptors spread themselves around. J Clin Endocrinol Metabol 79:1232–1238
10.
go back to reference Conde I et al (2006) Influence of thyroid hormone receptors on breast cancer cell proliferation. Ann Oncol 17(1):60–64CrossRefPubMed Conde I et al (2006) Influence of thyroid hormone receptors on breast cancer cell proliferation. Ann Oncol 17(1):60–64CrossRefPubMed
11.
go back to reference Kuijpens JL et al (2005) Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid 15(11):1253–1259CrossRefPubMed Kuijpens JL et al (2005) Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid 15(11):1253–1259CrossRefPubMed
12.
go back to reference Farahati J et al (2012) Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer. Clin Chem Lab Med 50(4):709–714CrossRefPubMed Farahati J et al (2012) Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer. Clin Chem Lab Med 50(4):709–714CrossRefPubMed
13.
go back to reference Muller I et al (2014) Does thyroid peroxidase provide an antigenic link between thyroid autoimmunity and breast cancer? Int J Cancer 134(7):1706–1714CrossRefPubMed Muller I et al (2014) Does thyroid peroxidase provide an antigenic link between thyroid autoimmunity and breast cancer? Int J Cancer 134(7):1706–1714CrossRefPubMed
14.
go back to reference Giustarini E et al (2006) Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 154(5):645–649CrossRefPubMed Giustarini E et al (2006) Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 154(5):645–649CrossRefPubMed
15.
go back to reference Prinzi N et al (2014) Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3,921 patients. Breast Cancer Res Treat 144(3):683–688CrossRefPubMed Prinzi N et al (2014) Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3,921 patients. Breast Cancer Res Treat 144(3):683–688CrossRefPubMed
16.
go back to reference Hardefeldt PJ et al (2012) Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat 133(3):1169–1177CrossRefPubMed Hardefeldt PJ et al (2012) Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat 133(3):1169–1177CrossRefPubMed
17.
go back to reference Gogas J et al (2001) Autoimmune thyroid disease in women with breast carcinoma. Eur J Surg Oncol 27:626–630CrossRefPubMed Gogas J et al (2001) Autoimmune thyroid disease in women with breast carcinoma. Eur J Surg Oncol 27:626–630CrossRefPubMed
18.
go back to reference Smyth PPA (2003) The thyroid, iodine and breast cancer. Breast Cancer Res 2003(5):235–238CrossRef Smyth PPA (2003) The thyroid, iodine and breast cancer. Breast Cancer Res 2003(5):235–238CrossRef
19.
go back to reference Giani G et al (1996) Relation between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metabol 81:990–994 Giani G et al (1996) Relation between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metabol 81:990–994
Metadata
Title
Breast cancer and thyroid diseases: analysis of 867 consecutive cases
Authors
C. Chiappa
F. Rovera
S. Rausei
S. Del Ferraro
A. Fachinetti
M. Lavazza
V. Marchionini
V. Arlant
M. L. Tanda
E. Piantanida
H. Y. Kim
A. Anuwong
G. Dionigi
Publication date
01-02-2017
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 2/2017
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-016-0543-4

Other articles of this Issue 2/2017

Journal of Endocrinological Investigation 2/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.